Current Pharmaceutical Design
Title:Editorial (Thematic Issue: Current Research on Cannabis Use Disorder)
Volume: 22 Issue: 42
Author(s): Aviv Weinstein
Affiliation:
Export Options
About this article
Cite this article as:
Weinstein Aviv, Editorial (Thematic Issue: Current Research on Cannabis Use Disorder), Current Pharmaceutical Design 2016; 22 (42) . https://dx.doi.org/10.2174/1381612822666160921102505
DOI https://dx.doi.org/10.2174/1381612822666160921102505 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
40
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Osteopontin as a Potential Therapeutic Target for Ischemic Stroke
Current Drug Delivery Neural Progenitors and HIV-1- Associated Central Nervous System Disease in Adults and Children
Current HIV Research Potential Therapeutic Strategies of Phytochemicals in Neurodegenerative Disorders
Current Topics in Medicinal Chemistry Intracerebrally Applied Botulinum Neurotoxin in Experimental Neuroscience
Current Pharmaceutical Biotechnology Anticonvulsants – Antidepressants Pharmacokinetic Drug Interactions: The Role of the CYP450 System in Psychopharmacology
Current Drug Metabolism Acid-Sensing Ion Channels Structural Aspects, Pathophysiological Importance and Experimental Mutational Data Available Across Various Species to Target Human ASIC1
Current Drug Targets Nitric Oxide, Epileptic Seizures, and Action of Antiepileptic Drugs
CNS & Neurological Disorders - Drug Targets In-vitro Antioxidant activity of ‘Aswathy Chooranam’- a Siddha Drug
Current Traditional Medicine The Molecular Basis of Conantokin Antagonism of NMDA Receptor Function
Current Drug Targets Neurotransmitter Regulation of Adult Neurogenesis: Putative Therapeutic Targets
CNS & Neurological Disorders - Drug Targets Revised Genetic Classification of Limb Girdle Muscular Dystrophies
Current Molecular Medicine A Case of Topiramate-Induced Epistaxis
Current Drug Safety Editorial: Advances in the Treatment of Neurodegenerative Diseases and Epilepsy
Current Pharmaceutical Design GABAA Receptor Channel Pharmacology
Current Pharmaceutical Design Is Adult Hippocampal Neurogenesis Really Relevant for the Treatment of Psychiatric Disorders?
Current Neuropharmacology Evaluation of Specific Antibody Responses in Patients with Selective IgA Deficiency and Ataxia Telangiectasia
Endocrine, Metabolic & Immune Disorders - Drug Targets Drug-induced Inhibition and Trafficking Disruption of ion Channels: Pathogenesis of QT Abnormalities and Drug-induced Fatal Arrhythmias
Current Cardiology Reviews Editorial (Hot Topic: Palmitoylethanolamide: Biochemistry, Pharmacology and Therapeutic Use of a Pleiotropic Anti-Inflammatory Lipid Mediator)
CNS & Neurological Disorders - Drug Targets Increased Epileptiform EEG Activity and Decreased Seizure Threshold in Arctic APP Transgenic Mouse Model of Alzheimer’s Disease
Current Alzheimer Research GABAergic Drugs for the Treatment of Migraine
CNS & Neurological Disorders - Drug Targets